CYP2C19 and acute coronary syndrome: used RWD on purchased prescription drugs, hospital discharge, death, and genotype for CYP2C19*2, CYP2C19*3, and CYP2C19*8 loss‐of‐function (LOF) variants from a cohort of prospective patients with acute coronary syndrome or symptomatic chronic coronary disease.